| Dr Mark David Lipetz, MD | |
|
41 E Lipoa Street, Suite 22, Kihei, HI 96753 | |
| (808) 891-1177 | |
| (808) 891-2255 |
| Full Name | Dr Mark David Lipetz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 41 E Lipoa Street, Kihei, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306919956 | NPI | - | NPPES |
| B0222659 | Other | HI | HMSA |
| 08885703 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 10263 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark David Lipetz, MD 535 Kupulav Drive, Kihei, HI 96753 Ph: (808) 874-1872 | Dr Mark David Lipetz, MD 41 E Lipoa Street, Suite 22, Kihei, HI 96753 Ph: (808) 891-1177 |
News Archive
Kareus Therapeutics SA, the private biotechnology company focused on the development of novel therapeutics for the unmet treatment of age-related and chronic diseases, today announces the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046, a first-in-class disease modifying new chemical entity discovered for the treatment of Alzheimer's disease using Kareus' proprietary bioenergetics and KARLECT platforms.
A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase understanding of molecular markers in drug-resistant ovarian cancer with a view to improving clinical treatment.
Assembly Bill 5502-B—transmitted to Governor Andrew Cuomo yesterday—would needlessly raise the cost of many prescriptions in New York by 10 percent, according to the Pharmaceutical Care Management Association. If enacted, the Bill would prohibit consumers from getting discounted prescriptions through mail-service pharmacies.
A federal program that provides billions in drug discounts to safety net hospitals and other health care providers is expanding under health care reform, but divergent views on the purpose and future scope of the program creates uncertainty for safety net providers and drug manufacturers, according to new report from the RAND Corporation.
› Verified 7 days ago
Melvin Daniel Burton, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 380 Huku Lii Pl, Suite 204, Kihei, HI 96753 Phone: 808-874-8774 Fax: 808-874-8947 | |
Maria Theresa David, D.O. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 3860 Wailea Alanui Drive,, Suite 102, Kihei, HI 96753 Phone: 808-875-1270 Fax: 808-875-1281 | |
Dr. Peter Daniel Muthard, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 380 Huku Lii Pl, Suite 204, Kihei, HI 96753 Phone: 808-874-8774 | |
Dr. Kenneth B Kepler, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 Piikea Ave # A, Kihei, HI 96753 Phone: 808-270-0491 Fax: 808-874-6887 | |
Dr. Loma Harrison Hassell Ii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 567 Kupulau Dr, Kihei, HI 96753 Phone: 808-280-9638 Fax: 844-342-7003 |